Xeris Biopharma Holdings, Inc. · NASDAQ:XERS
Johnson John sold 15,000 Xeris Biopharma Holdings, Inc. shares (Form 4)
Traded Jun 4, 2026 · Filed Jun 5, 2026
On Jun 4, 2026, Johnson John (Director) sold 15,000 Xeris Biopharma Holdings, Inc. shares at US$6.09 for US$91,350 under a trading plan, leaving 707,276 shares. Filed Jun 5, 2026 (Form 4).
- Sold
- 15,000 shares
- Price
- US$6.09
- Value
- US$91,350
- Holding after
- 707,276 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Common Stock | Sale | 15,000 | US$6.09 | 683,083 | Direct |
| Jun 4, 2026 | Common Stock | Award | 24,193 | 707,276 | Direct |